

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | retinal rod cell development (GO:0046548) | 9.50426696 |
| 2 | * detection of light stimulus involved in visual perception (GO:0050908) | 9.33421276 |
| 3 | * detection of light stimulus involved in sensory perception (GO:0050962) | 9.33421276 |
| 4 | retinal cone cell development (GO:0046549) | 7.78978344 |
| 5 | rhodopsin mediated signaling pathway (GO:0016056) | 7.22751590 |
| 6 | photoreceptor cell maintenance (GO:0045494) | 7.18538666 |
| 7 | photoreceptor cell development (GO:0042461) | 7.06006718 |
| 8 | eye photoreceptor cell development (GO:0042462) | 7.01786192 |
| 9 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.88223365 |
| 10 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 6.50948206 |
| 11 | cellular potassium ion homeostasis (GO:0030007) | 6.10444442 |
| 12 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 6.07629193 |
| 13 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.80679880 |
| 14 | response to peptidoglycan (GO:0032494) | 5.52084844 |
| 15 | protein-chromophore linkage (GO:0018298) | 5.33007405 |
| 16 | potassium ion homeostasis (GO:0055075) | 5.17327998 |
| 17 | relaxation of smooth muscle (GO:0044557) | 5.13997133 |
| 18 | sodium ion export (GO:0071436) | 5.07750711 |
| 19 | neutrophil activation involved in immune response (GO:0002283) | 5.06646063 |
| 20 | sensory perception of light stimulus (GO:0050953) | 5.05690125 |
| 21 | visual perception (GO:0007601) | 5.05358693 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 5.04952299 |
| 23 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.94890594 |
| 24 | protein localization to synapse (GO:0035418) | 4.94059230 |
| 25 | synaptic vesicle endocytosis (GO:0048488) | 4.91549330 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 4.61892702 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 4.59474702 |
| 28 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.52455603 |
| 29 | * detection of visible light (GO:0009584) | 4.45907473 |
| 30 | * detection of light stimulus (GO:0009583) | 4.45283012 |
| 31 | membrane hyperpolarization (GO:0060081) | 4.31845575 |
| 32 | nonmotile primary cilium assembly (GO:0035058) | 4.29908708 |
| 33 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.26110994 |
| 34 | modulation by symbiont of host immune response (GO:0052553) | 4.26110994 |
| 35 | positive regulation by symbiont of host defense response (GO:0052509) | 4.26110994 |
| 36 | modulation by symbiont of host defense response (GO:0052031) | 4.26110994 |
| 37 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.26110994 |
| 38 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.26110994 |
| 39 | cellular extravasation (GO:0045123) | 4.19531065 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 4.17056964 |
| 41 | GMP metabolic process (GO:0046037) | 4.15333584 |
| 42 | phototransduction (GO:0007602) | 4.04289328 |
| 43 | eye photoreceptor cell differentiation (GO:0001754) | 4.02144904 |
| 44 | photoreceptor cell differentiation (GO:0046530) | 4.02144904 |
| 45 | retina development in camera-type eye (GO:0060041) | 4.02118261 |
| 46 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.01998615 |
| 47 | innervation (GO:0060384) | 3.98578984 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.92428594 |
| 49 | response to muramyl dipeptide (GO:0032495) | 3.92216726 |
| 50 | macrophage activation involved in immune response (GO:0002281) | 3.92123211 |
| 51 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.92033257 |
| 52 | urinary tract smooth muscle contraction (GO:0014848) | 3.91482804 |
| 53 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.90975676 |
| 54 | phototransduction, visible light (GO:0007603) | 3.89213072 |
| 55 | immunoglobulin mediated immune response (GO:0016064) | 3.89015184 |
| 56 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.81077692 |
| 57 | negative regulation of cell killing (GO:0031342) | 3.81077692 |
| 58 | calcium ion import (GO:0070509) | 3.78103819 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.77064091 |
| 60 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.72803898 |
| 61 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.72411832 |
| 62 | pinocytosis (GO:0006907) | 3.71175729 |
| 63 | mannose metabolic process (GO:0006013) | 3.67759237 |
| 64 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 3.66062908 |
| 65 | regulation of synapse maturation (GO:0090128) | 3.65340489 |
| 66 | cellular response to light stimulus (GO:0071482) | 3.63495139 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.61782361 |
| 68 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.59671112 |
| 69 | oligosaccharide catabolic process (GO:0009313) | 3.56008960 |
| 70 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.55369078 |
| 71 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.55134059 |
| 72 | detection of molecule of bacterial origin (GO:0032490) | 3.52429972 |
| 73 | cellular sodium ion homeostasis (GO:0006883) | 3.50664653 |
| 74 | mating behavior (GO:0007617) | 3.50066238 |
| 75 | detection of other organism (GO:0098543) | 3.49661010 |
| 76 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.45462298 |
| 77 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45071583 |
| 78 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.43446991 |
| 79 | tachykinin receptor signaling pathway (GO:0007217) | 3.42724800 |
| 80 | regulation of leukocyte degranulation (GO:0043300) | 3.41929183 |
| 81 | granulocyte activation (GO:0036230) | 3.38487671 |
| 82 | positive regulation of mast cell activation (GO:0033005) | 3.34503354 |
| 83 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.34267156 |
| 84 | regulation of cGMP metabolic process (GO:0030823) | 3.33812512 |
| 85 | behavioral response to ethanol (GO:0048149) | 3.33558112 |
| 86 | myeloid cell activation involved in immune response (GO:0002275) | 3.33309053 |
| 87 | neutrophil activation (GO:0042119) | 3.33071578 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.32846299 |
| 89 | striatum development (GO:0021756) | 3.31656936 |
| 90 | positive regulation of gastrulation (GO:2000543) | 3.31603644 |
| 91 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.30677873 |
| 92 | * detection of external stimulus (GO:0009581) | 3.29227340 |
| 93 | * detection of abiotic stimulus (GO:0009582) | 3.28659396 |
| 94 | detection of bacterium (GO:0016045) | 3.27449455 |
| 95 | cell communication by electrical coupling (GO:0010644) | 3.24984577 |
| 96 | glycosphingolipid catabolic process (GO:0046479) | 3.24567652 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 3.23655235 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.23402999 |
| 99 | synaptic vesicle maturation (GO:0016188) | 3.23096484 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 3.22846574 |
| 101 | myeloid dendritic cell activation (GO:0001773) | 3.22324946 |
| 102 | detection of external biotic stimulus (GO:0098581) | 3.20738831 |
| 103 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.20145225 |
| 104 | regulation of cGMP biosynthetic process (GO:0030826) | 3.18933266 |
| 105 | regulation of mast cell activation (GO:0033003) | 3.18230689 |
| 106 | positive regulation of mast cell degranulation (GO:0043306) | 3.17332378 |
| 107 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.17332378 |
| 108 | establishment of synaptic vesicle localization (GO:0097480) | 3.14920950 |
| 109 | synaptic vesicle transport (GO:0048489) | 3.14920950 |
| 110 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.14119977 |
| 111 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.13973964 |
| 112 | regulation of synaptic vesicle transport (GO:1902803) | 3.12678707 |
| 113 | righting reflex (GO:0060013) | 3.11688418 |
| 114 | positive regulation of B cell differentiation (GO:0045579) | 3.09919313 |
| 115 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09131598 |
| 116 | positive regulation of cGMP metabolic process (GO:0030825) | 3.07195986 |
| 117 | regulation of catecholamine metabolic process (GO:0042069) | 3.04993267 |
| 118 | regulation of dopamine metabolic process (GO:0042053) | 3.04993267 |
| 119 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.04800685 |
| 120 | estrogen biosynthetic process (GO:0006703) | 3.04691860 |
| 121 | glutamate receptor signaling pathway (GO:0007215) | 3.04245418 |
| 122 | detection of biotic stimulus (GO:0009595) | 3.02415986 |
| 123 | pyrimidine dimer repair (GO:0006290) | 3.01485750 |
| 124 | macrophage activation (GO:0042116) | 2.99627370 |
| 125 | macrophage differentiation (GO:0030225) | 2.98269104 |
| 126 | potassium ion export (GO:0071435) | 2.98263935 |
| 127 | regulation of superoxide anion generation (GO:0032928) | 2.97382941 |
| 128 | T cell migration (GO:0072678) | 2.97138876 |
| 129 | regulation of hypersensitivity (GO:0002883) | 2.96831129 |
| 130 | sialylation (GO:0097503) | 2.95638657 |
| 131 | regulation of macrophage chemotaxis (GO:0010758) | 2.94222411 |
| 132 | response to histamine (GO:0034776) | 2.93238040 |
| 133 | atrial cardiac muscle cell action potential (GO:0086014) | 2.91980103 |
| 134 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.90764365 |
| 135 | regulation of neurotransmitter secretion (GO:0046928) | 2.90421825 |
| 136 | B cell mediated immunity (GO:0019724) | 2.90204329 |
| 137 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90200754 |
| 138 | germinal center formation (GO:0002467) | 2.89952193 |
| 139 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.89810195 |
| 140 | glycolipid catabolic process (GO:0019377) | 2.89715525 |
| 141 | NIK/NF-kappaB signaling (GO:0038061) | 2.89298003 |
| 142 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.88527270 |
| 143 | response to protozoan (GO:0001562) | 2.88410195 |
| 144 | lactate metabolic process (GO:0006089) | 2.88262734 |
| 145 | response to thyroid hormone (GO:0097066) | 2.86630702 |
| 146 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.86293478 |
| 147 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.85883366 |
| 148 | response to host (GO:0075136) | 2.85883366 |
| 149 | response to host defenses (GO:0052200) | 2.85883366 |
| 150 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.85713360 |
| 151 | neutrophil mediated immunity (GO:0002446) | 2.85504115 |
| 152 | membrane depolarization during action potential (GO:0086010) | 2.85200135 |
| 153 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83289400 |
| 154 | nitric oxide mediated signal transduction (GO:0007263) | 2.83161105 |
| 155 | regulation of tolerance induction (GO:0002643) | 2.82620580 |
| 156 | defense response to protozoan (GO:0042832) | 2.82535263 |
| 157 | neuron-neuron synaptic transmission (GO:0007270) | 2.81171567 |
| 158 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.80226294 |
| 159 | response to host immune response (GO:0052572) | 2.80174620 |
| 160 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80174620 |
| 161 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.79506403 |
| 162 | respiratory burst (GO:0045730) | 2.79162942 |
| 163 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.78817312 |
| 164 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.78449852 |
| 165 | auditory receptor cell stereocilium organization (GO:0060088) | 2.78363679 |
| 166 | positive regulation of leukocyte degranulation (GO:0043302) | 2.77157625 |
| 167 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.76955674 |
| 168 | long term synaptic depression (GO:0060292) | 2.76566115 |
| 169 | regulation of T cell tolerance induction (GO:0002664) | 2.76376365 |
| 170 | negative regulation of T cell mediated immunity (GO:0002710) | 2.75946519 |
| 171 | retinal ganglion cell axon guidance (GO:0031290) | 2.75469117 |
| 172 | microglial cell activation (GO:0001774) | 2.75252619 |
| 173 | dentate gyrus development (GO:0021542) | 2.74719985 |
| 174 | potassium ion transmembrane transport (GO:0071805) | 2.74221055 |
| 175 | cellular potassium ion transport (GO:0071804) | 2.74221055 |
| 176 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.74000368 |
| 177 | potassium ion import (GO:0010107) | 2.73764003 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.73459878 |
| 179 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.73430073 |
| 180 | low-density lipoprotein particle clearance (GO:0034383) | 2.73296538 |
| 181 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73272533 |
| 182 | negative regulation of granulocyte differentiation (GO:0030853) | 2.71923765 |
| 183 | leukocyte aggregation (GO:0070486) | 2.70970412 |
| 184 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.70883900 |
| 185 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.70883900 |
| 186 | myeloid leukocyte activation (GO:0002274) | 2.68727853 |
| 187 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.65800094 |
| 188 | regulation of regulated secretory pathway (GO:1903305) | 2.65381427 |
| 189 | leukocyte degranulation (GO:0043299) | 2.64979669 |
| 190 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.63205715 |
| 191 | plasma lipoprotein particle assembly (GO:0034377) | 2.62685969 |
| 192 | positive regulation of phagocytosis (GO:0050766) | 2.61657995 |
| 193 | T-helper 1 type immune response (GO:0042088) | 2.60739617 |
| 194 | B cell receptor signaling pathway (GO:0050853) | 2.60167104 |
| 195 | positive regulation of extracellular matrix organization (GO:1903055) | 2.59717779 |
| 196 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.58000728 |
| 197 | mature B cell differentiation (GO:0002335) | 2.57338418 |
| 198 | response to pheromone (GO:0019236) | 12.5649318 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.73339857 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.50332530 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 4.22388362 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.20994004 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.87475299 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.57385301 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.44202719 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.32230071 |
| 9 | VDR_24763502_ChIP-Seq_THP-1_Human | 3.32187184 |
| 10 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.25424755 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.16301344 |
| 12 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.00165879 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.94087750 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77222484 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.54902319 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.53970582 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53487614 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.52937500 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41165972 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.40633260 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.39319498 |
| 22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.36446315 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.35959373 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34258784 |
| 25 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.31268426 |
| 26 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.31095869 |
| 27 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.28986344 |
| 28 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.28817768 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.28637352 |
| 30 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.26844551 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.22860530 |
| 32 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.20460441 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 2.18506497 |
| 34 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.17346579 |
| 35 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.13507184 |
| 36 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13022907 |
| 37 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.10675280 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09097358 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 2.08630310 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.06826245 |
| 41 | MAF_26560356_Chip-Seq_TH1_Human | 2.06419989 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.06385970 |
| 43 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.05622584 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.04701199 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.04359996 |
| 46 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.00371824 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99758970 |
| 48 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.99603473 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.99243036 |
| 50 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.97235199 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.96448646 |
| 52 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.96448646 |
| 53 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96181084 |
| 54 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94979463 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93171823 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.93108971 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91990451 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90471871 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.90243837 |
| 60 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.89492403 |
| 61 | MYB_26560356_Chip-Seq_TH2_Human | 1.88060749 |
| 62 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.86434306 |
| 63 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.86230071 |
| 64 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.84639059 |
| 65 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84319068 |
| 66 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.80661877 |
| 67 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.79051755 |
| 68 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.78266273 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75583320 |
| 70 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.74869220 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.72939824 |
| 72 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.72382994 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71115820 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.70919663 |
| 75 | MYB_26560356_Chip-Seq_TH1_Human | 1.70521087 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.70159862 |
| 77 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.67939977 |
| 78 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67020468 |
| 79 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65605333 |
| 80 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.64459922 |
| 81 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.64385008 |
| 82 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64232348 |
| 83 | P300_19829295_ChIP-Seq_ESCs_Human | 1.63715028 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.62318499 |
| 85 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.60967530 |
| 86 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60118016 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.59619656 |
| 88 | MAF_26560356_Chip-Seq_TH2_Human | 1.59383876 |
| 89 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57053594 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55441924 |
| 91 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54790226 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53128912 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.52903130 |
| 94 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51812859 |
| 95 | FUS_26573619_Chip-Seq_HEK293_Human | 1.49486305 |
| 96 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48592587 |
| 97 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48487642 |
| 98 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.46586888 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46137357 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45953152 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45874272 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45440713 |
| 103 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45221981 |
| 104 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.44825716 |
| 105 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.42353371 |
| 106 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41093844 |
| 107 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.40494562 |
| 108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40344820 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.39660655 |
| 110 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39141501 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.38051742 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36554243 |
| 113 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.36382235 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35893443 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.34033443 |
| 116 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33632526 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.33567580 |
| 118 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32767273 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.32722290 |
| 120 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32477030 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31981905 |
| 122 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31595014 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.31107385 |
| 124 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29660834 |
| 125 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29656573 |
| 126 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.29627257 |
| 127 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.28454675 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.28354558 |
| 129 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.28183774 |
| 130 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26485693 |
| 131 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25829594 |
| 132 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24424033 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24393127 |
| 134 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.23175678 |
| 135 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22260131 |
| 136 | * AR_19668381_ChIP-Seq_PC3_Human | 1.21996137 |
| 137 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.21944340 |
| 138 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.21849744 |
| 139 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.21628730 |
| 140 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.20874630 |
| 141 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.19006341 |
| 142 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.18107031 |
| 143 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17955760 |
| 144 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.17117995 |
| 145 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16144467 |
| 146 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15063272 |
| 147 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.14952454 |
| 148 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.14851975 |
| 149 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14698699 |
| 150 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.14107310 |
| 151 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.14102686 |
| 152 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12408286 |
| 153 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.11549339 |
| 154 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10784304 |
| 155 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09898843 |
| 156 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.09452231 |
| 157 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09249793 |
| 158 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.09214568 |
| 159 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09047960 |
| 160 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.08998066 |
| 161 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08110474 |
| 162 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06839616 |
| 163 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06683634 |
| 164 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06008460 |
| 165 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05617289 |
| 166 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05617289 |
| 167 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04744726 |
| 168 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.04569956 |
| 169 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04228514 |
| 170 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03864736 |
| 171 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03073379 |
| 172 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.01707168 |
| 173 | TBL1_22424771_ChIP-Seq_293T_Human | 1.01680114 |
| 174 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01393946 |
| 175 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.00328953 |
| 176 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99705729 |
| 177 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99643807 |
| 178 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99515548 |
| 179 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.99515548 |
| 180 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98853702 |
| 181 | KDM2B_26808549_Chip-Seq_REH_Human | 0.98671438 |
| 182 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.97120990 |
| 183 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96589663 |
| 184 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95776200 |
| 185 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95720272 |
| 186 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95137699 |
| 187 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94834153 |
| 188 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.94734463 |
| 189 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94255442 |
| 190 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94146735 |
| 191 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.92472008 |
| 192 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.92347730 |
| 193 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92318433 |
| 194 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91770576 |
| 195 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90197988 |
| 196 | P68_20966046_ChIP-Seq_HELA_Human | 0.88280943 |
| 197 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87323359 |
| 198 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85745424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 7.78666782 |
| 2 | MP0006072_abnormal_retinal_apoptosis | 5.28916957 |
| 3 | MP0003011_delayed_dark_adaptation | 4.89291883 |
| 4 | MP0005253_abnormal_eye_physiology | 4.67984836 |
| 5 | MP0002090_abnormal_vision | 4.12867769 |
| 6 | MP0005058_abnormal_lysosome_morphology | 4.05822962 |
| 7 | MP0003436_decreased_susceptibility_to | 3.85250691 |
| 8 | MP0001984_abnormal_olfaction | 3.73304530 |
| 9 | MP0003303_peritoneal_inflammation | 3.66148907 |
| 10 | MP0003950_abnormal_plasma_membrane | 3.63889829 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.26865472 |
| 12 | MP0006292_abnormal_olfactory_placode | 3.20231203 |
| 13 | * MP0005195_abnormal_posterior_eye | 3.11778250 |
| 14 | MP0002419_abnormal_innate_immunity | 2.99197125 |
| 15 | MP0006082_CNS_inflammation | 2.97226588 |
| 16 | MP0001502_abnormal_circadian_rhythm | 2.96980599 |
| 17 | MP0009840_abnormal_foam_cell | 2.77697704 |
| 18 | MP0009785_altered_susceptibility_to | 2.67661400 |
| 19 | MP0002638_abnormal_pupillary_reflex | 2.67152275 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.65863810 |
| 21 | MP0003724_increased_susceptibility_to | 2.63638304 |
| 22 | MP0005025_abnormal_response_to | 2.63336604 |
| 23 | MP0005671_abnormal_response_to | 2.54014383 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.53121117 |
| 25 | MP0001324_abnormal_eye_pigmentation | 2.52708700 |
| 26 | MP0004782_abnormal_surfactant_physiolog | 2.44610264 |
| 27 | MP0009278_abnormal_bone_marrow | 2.39501109 |
| 28 | MP0005423_abnormal_somatic_nervous | 2.33721402 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 2.32082512 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.29681391 |
| 31 | MP0001800_abnormal_humoral_immune | 2.25705449 |
| 32 | MP0001790_abnormal_immune_system | 2.24402691 |
| 33 | MP0005387_immune_system_phenotype | 2.24402691 |
| 34 | MP0000685_abnormal_immune_system | 2.21611728 |
| 35 | MP0003300_gastrointestinal_ulcer | 2.21427027 |
| 36 | MP0002452_abnormal_antigen_presenting | 2.20939986 |
| 37 | MP0002723_abnormal_immune_serum | 2.19724871 |
| 38 | MP0001486_abnormal_startle_reflex | 2.18943836 |
| 39 | MP0005391_vision/eye_phenotype | 2.17497888 |
| 40 | MP0002229_neurodegeneration | 2.10130188 |
| 41 | MP0005451_abnormal_body_composition | 2.06327001 |
| 42 | MP0002420_abnormal_adaptive_immunity | 2.03658840 |
| 43 | MP0004233_abnormal_muscle_weight | 2.02906538 |
| 44 | MP0001819_abnormal_immune_cell | 2.01883174 |
| 45 | MP0003880_abnormal_central_pattern | 2.01117228 |
| 46 | MP0001346_abnormal_lacrimal_gland | 1.97534157 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.95407158 |
| 48 | MP0001853_heart_inflammation | 1.94025623 |
| 49 | MP0002139_abnormal_hepatobiliary_system | 1.92426492 |
| 50 | MP0002752_abnormal_somatic_nervous | 1.88658198 |
| 51 | MP0000604_amyloidosis | 1.87363862 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.80926096 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.80926096 |
| 54 | MP0002405_respiratory_system_inflammati | 1.80128128 |
| 55 | MP0003075_altered_response_to | 1.76575930 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.69364632 |
| 57 | MP0005499_abnormal_olfactory_system | 1.68866111 |
| 58 | MP0005394_taste/olfaction_phenotype | 1.68866111 |
| 59 | MP0008789_abnormal_olfactory_epithelium | 1.68337131 |
| 60 | MP0001845_abnormal_inflammatory_respons | 1.67484609 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.66420864 |
| 62 | MP0002272_abnormal_nervous_system | 1.64600293 |
| 63 | MP0005670_abnormal_white_adipose | 1.64419292 |
| 64 | MP0008469_abnormal_protein_level | 1.63831549 |
| 65 | MP0010386_abnormal_urinary_bladder | 1.62297513 |
| 66 | MP0004947_skin_inflammation | 1.60692745 |
| 67 | MP0010155_abnormal_intestine_physiology | 1.60001708 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.59598158 |
| 69 | MP0003828_pulmonary_edema | 1.59305532 |
| 70 | MP0004510_myositis | 1.56030398 |
| 71 | MP0008260_abnormal_autophagy | 1.55764450 |
| 72 | MP0000716_abnormal_immune_system | 1.54960048 |
| 73 | MP0009764_decreased_sensitivity_to | 1.51185236 |
| 74 | MP0000858_altered_metastatic_potential | 1.47681468 |
| 75 | MP0002398_abnormal_bone_marrow | 1.47481930 |
| 76 | MP0003635_abnormal_synaptic_transmissio | 1.44384725 |
| 77 | MP0009046_muscle_twitch | 1.43879904 |
| 78 | MP0002064_seizures | 1.43056500 |
| 79 | MP0010030_abnormal_orbit_morphology | 1.41265577 |
| 80 | MP0000343_altered_response_to | 1.41205028 |
| 81 | MP0002882_abnormal_neuron_morphology | 1.40540849 |
| 82 | MP0002067_abnormal_sensory_capabilities | 1.37909459 |
| 83 | MP0000631_abnormal_neuroendocrine_gland | 1.37513730 |
| 84 | MP0000689_abnormal_spleen_morphology | 1.36875831 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.36656382 |
| 86 | MP0001188_hyperpigmentation | 1.35426257 |
| 87 | MP0002734_abnormal_mechanical_nocicepti | 1.30752194 |
| 88 | MP0002722_abnormal_immune_system | 1.28011169 |
| 89 | MP0004742_abnormal_vestibular_system | 1.27790214 |
| 90 | MP0001968_abnormal_touch/_nociception | 1.27788064 |
| 91 | MP0002429_abnormal_blood_cell | 1.27208896 |
| 92 | MP0003690_abnormal_glial_cell | 1.27110640 |
| 93 | MP0004215_abnormal_myocardial_fiber | 1.25188202 |
| 94 | MP0003763_abnormal_thymus_physiology | 1.25111845 |
| 95 | MP0005167_abnormal_blood-brain_barrier | 1.24628198 |
| 96 | MP0002132_abnormal_respiratory_system | 1.24448105 |
| 97 | MP0002933_joint_inflammation | 1.24383414 |
| 98 | MP0003806_abnormal_nucleotide_metabolis | 1.23872309 |
| 99 | MP0005310_abnormal_salivary_gland | 1.20597018 |
| 100 | MP0002063_abnormal_learning/memory/cond | 1.18625193 |
| 101 | MP0002184_abnormal_innervation | 1.18466690 |
| 102 | MP0008775_abnormal_heart_ventricle | 1.17501346 |
| 103 | MP0009745_abnormal_behavioral_response | 1.14084155 |
| 104 | MP0005360_urolithiasis | 1.13861577 |
| 105 | MP0002572_abnormal_emotion/affect_behav | 1.13609590 |
| 106 | MP0003879_abnormal_hair_cell | 1.13372288 |
| 107 | MP0006054_spinal_hemorrhage | 1.13066312 |
| 108 | MP0005365_abnormal_bile_salt | 1.09868658 |
| 109 | MP0002653_abnormal_ependyma_morphology | 1.07210256 |
| 110 | MP0005166_decreased_susceptibility_to | 1.06991335 |
| 111 | MP0002277_abnormal_respiratory_mucosa | 1.06388192 |
| 112 | MP0003448_altered_tumor_morphology | 1.04616134 |
| 113 | MP0004859_abnormal_synaptic_plasticity | 1.02931364 |
| 114 | MP0005076_abnormal_cell_differentiation | 1.02396687 |
| 115 | MP0005595_abnormal_vascular_smooth | 1.01965144 |
| 116 | MP0005164_abnormal_response_to | 1.01783333 |
| 117 | MP0000566_synostosis | 1.01399609 |
| 118 | MP0001986_abnormal_taste_sensitivity | 1.01174231 |
| 119 | MP0002736_abnormal_nociception_after | 0.98886374 |
| 120 | MP0002332_abnormal_exercise_endurance | 0.98056787 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.97165642 |
| 122 | MP0008004_abnormal_stomach_pH | 0.94370286 |
| 123 | MP0002166_altered_tumor_susceptibility | 0.94246386 |
| 124 | MP0004883_abnormal_blood_vessel | 0.94150173 |
| 125 | MP0002735_abnormal_chemical_nociception | 0.94126642 |
| 126 | MP0001851_eye_inflammation | 0.93806391 |
| 127 | MP0002396_abnormal_hematopoietic_system | 0.93691409 |
| 128 | MP0004145_abnormal_muscle_electrophysio | 0.93273086 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.92682943 |
| 130 | MP0004142_abnormal_muscle_tone | 0.91343838 |
| 131 | MP0004885_abnormal_endolymph | 0.90208439 |
| 132 | MP0009763_increased_sensitivity_to | 0.89673083 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.89477826 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.89252465 |
| 135 | MP0009697_abnormal_copulation | 0.88825195 |
| 136 | MP0003329_amyloid_beta_deposits | 0.88475458 |
| 137 | MP0003453_abnormal_keratinocyte_physiol | 0.88396956 |
| 138 | MP0000703_abnormal_thymus_morphology | 0.87240216 |
| 139 | MP0000609_abnormal_liver_physiology | 0.87186431 |
| 140 | MP0004808_abnormal_hematopoietic_stem | 0.85843944 |
| 141 | MP0003634_abnormal_glial_cell | 0.84399665 |
| 142 | MP0003868_abnormal_feces_composition | 0.83672489 |
| 143 | MP0003866_abnormal_defecation | 0.82239169 |
| 144 | MP0002557_abnormal_social/conspecific_i | 0.81670949 |
| 145 | MP0008569_lethality_at_weaning | 0.81211194 |
| 146 | MP0001529_abnormal_vocalization | 0.80937819 |
| 147 | MP0000920_abnormal_myelination | 0.79721008 |
| 148 | MP0003195_calcinosis | 0.76826789 |
| 149 | MP0005390_skeleton_phenotype | 0.76009737 |
| 150 | MP0004036_abnormal_muscle_relaxation | 0.75814017 |
| 151 | MP0003137_abnormal_impulse_conducting | 0.75701943 |
| 152 | MP0003890_abnormal_embryonic-extraembry | 0.75352646 |
| 153 | MP0000534_abnormal_ureter_morphology | 0.73873573 |
| 154 | MP0001873_stomach_inflammation | 0.73807969 |
| 155 | MP0003795_abnormal_bone_structure | 0.72907766 |
| 156 | MP0004043_abnormal_pH_regulation | 0.72814540 |
| 157 | MP0000249_abnormal_blood_vessel | 0.71703159 |
| 158 | MP0010329_abnormal_lipoprotein_level | 0.71672549 |
| 159 | MP0002009_preneoplasia | 0.70839368 |
| 160 | MP0001501_abnormal_sleep_pattern | 0.70613656 |
| 161 | MP0005666_abnormal_adipose_tissue | 0.70092663 |
| 162 | MP0004185_abnormal_adipocyte_glucose | 0.68896054 |
| 163 | MP0000026_abnormal_inner_ear | 0.68885242 |
| 164 | MP0005386_behavior/neurological_phenoty | 0.66528997 |
| 165 | MP0004924_abnormal_behavior | 0.66528997 |
| 166 | MP0001970_abnormal_pain_threshold | 0.66267831 |
| 167 | MP0006276_abnormal_autonomic_nervous | 0.65234590 |
| 168 | MP0005410_abnormal_fertilization | 0.64582760 |
| 169 | MP0001663_abnormal_digestive_system | 0.64227707 |
| 170 | MP0002006_tumorigenesis | 0.63318247 |
| 171 | MP0000955_abnormal_spinal_cord | 0.62881030 |
| 172 | MP0005646_abnormal_pituitary_gland | 0.62472080 |
| 173 | MP0004084_abnormal_cardiac_muscle | 0.62123544 |
| 174 | MP0002138_abnormal_hepatobiliary_system | 0.61680184 |
| 175 | MP0005197_abnormal_uvea_morphology | 0.61437574 |
| 176 | MP0009115_abnormal_fat_cell | 0.60840860 |
| 177 | MP0005319_abnormal_enzyme/_coenzyme | 0.60481778 |
| 178 | MP0002127_abnormal_cardiovascular_syste | 0.60414283 |
| 179 | MP0003091_abnormal_cell_migration | 0.59962573 |
| 180 | MP0001915_intracranial_hemorrhage | 0.59809344 |
| 181 | MP0002697_abnormal_eye_size | 0.59247014 |
| 182 | MP0004085_abnormal_heartbeat | 0.58798554 |
| 183 | MP0002066_abnormal_motor_capabilities/c | 0.58652409 |
| 184 | MP0000569_abnormal_digit_pigmentation | 0.58481548 |
| 185 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58218959 |
| 186 | MP0004019_abnormal_vitamin_homeostasis | 0.56989416 |
| 187 | MP0004270_analgesia | 0.56907557 |
| 188 | MP0002069_abnormal_eating/drinking_beha | 0.54710536 |
| 189 | MP0002152_abnormal_brain_morphology | 0.54578437 |
| 190 | MP0003045_fibrosis | 0.54188227 |
| 191 | MP0001270_distended_abdomen | 0.52705481 |
| 192 | MP0003172_abnormal_lysosome_physiology | 0.51862725 |
| 193 | MP0000778_abnormal_nervous_system | 0.51067801 |
| 194 | MP0005645_abnormal_hypothalamus_physiol | 0.49907910 |
| 195 | MP0001286_abnormal_eye_development | 0.48608436 |
| 196 | MP0003183_abnormal_peptide_metabolism | 0.48593658 |
| 197 | MP0003698_abnormal_male_reproductive | 0.47461110 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Central scotoma (HP:0000603) | 8.73160470 |
| 2 | Abnormal rod and cone electroretinograms (HP:0008323) | 8.34658954 |
| 3 | Abnormality of macular pigmentation (HP:0008002) | 8.10970989 |
| 4 | Bony spicule pigmentary retinopathy (HP:0007737) | 7.50175654 |
| 5 | Severe visual impairment (HP:0001141) | 7.27030951 |
| 6 | Decreased central vision (HP:0007663) | 6.84009247 |
| 7 | Scotoma (HP:0000575) | 6.44945835 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 6.08922340 |
| 9 | Septo-optic dysplasia (HP:0100842) | 5.35925556 |
| 10 | Attenuation of retinal blood vessels (HP:0007843) | 5.23067434 |
| 11 | Abnormality of macrophages (HP:0004311) | 4.91475928 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.87483631 |
| 13 | Dyschromatopsia (HP:0007641) | 4.85194866 |
| 14 | Pendular nystagmus (HP:0012043) | 4.82274500 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 4.76585179 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 4.74755698 |
| 17 | Keratoconus (HP:0000563) | 4.73280527 |
| 18 | Increased corneal curvature (HP:0100692) | 4.73280527 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 4.64530576 |
| 20 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.64530576 |
| 21 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.64530576 |
| 22 | Vacuolated lymphocytes (HP:0001922) | 4.49636037 |
| 23 | Eczematoid dermatitis (HP:0000976) | 4.36282998 |
| 24 | Myositis (HP:0100614) | 4.30517428 |
| 25 | Pigmentary retinal degeneration (HP:0001146) | 4.25755255 |
| 26 | Dysostosis multiplex (HP:0000943) | 4.25669586 |
| 27 | Systemic lupus erythematosus (HP:0002725) | 4.13973046 |
| 28 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.06712631 |
| 29 | Chorioretinal atrophy (HP:0000533) | 3.98471870 |
| 30 | Stomatitis (HP:0010280) | 3.97905322 |
| 31 | Amyloidosis (HP:0011034) | 3.92623904 |
| 32 | Congenital sensorineural hearing impairment (HP:0008527) | 3.81102663 |
| 33 | Orchitis (HP:0100796) | 3.76457657 |
| 34 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.74012021 |
| 35 | Cone-rod dystrophy (HP:0000548) | 3.72767940 |
| 36 | Febrile seizures (HP:0002373) | 3.68414618 |
| 37 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.65884454 |
| 38 | Hypoplasia of the fovea (HP:0007750) | 3.65884454 |
| 39 | Optic neuritis (HP:0100653) | 3.63131645 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 3.63131645 |
| 41 | * Photophobia (HP:0000613) | 3.56532218 |
| 42 | Epileptic encephalopathy (HP:0200134) | 3.50901619 |
| 43 | Mediastinal lymphadenopathy (HP:0100721) | 3.48177791 |
| 44 | Purpura (HP:0000979) | 3.47516531 |
| 45 | Type II diabetes mellitus (HP:0005978) | 3.42933979 |
| 46 | Recurrent skin infections (HP:0001581) | 3.36148158 |
| 47 | Obstructive lung disease (HP:0006536) | 3.29979807 |
| 48 | Chronic obstructive pulmonary disease (HP:0006510) | 3.29979807 |
| 49 | Recurrent fungal infections (HP:0002841) | 3.23238010 |
| 50 | Deep venous thrombosis (HP:0002625) | 3.22752860 |
| 51 | Albinism (HP:0001022) | 3.16337164 |
| 52 | Retinitis pigmentosa (HP:0000510) | 3.12486512 |
| 53 | Loss of speech (HP:0002371) | 3.12042703 |
| 54 | Glomerulonephritis (HP:0000099) | 3.11549405 |
| 55 | Abnormality of the fovea (HP:0000493) | 3.08065612 |
| 56 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.03671825 |
| 57 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.03671825 |
| 58 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.03671825 |
| 59 | Mucopolysacchariduria (HP:0008155) | 3.03345451 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.03345451 |
| 61 | Recurrent cutaneous fungal infections (HP:0011370) | 2.94138900 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.94138900 |
| 63 | Disinhibition (HP:0000734) | 2.89924797 |
| 64 | Absent septum pellucidum (HP:0001331) | 2.89749065 |
| 65 | Macular degeneration (HP:0000608) | 2.89575128 |
| 66 | Increased serum ferritin (HP:0003281) | 2.78389260 |
| 67 | Meningitis (HP:0001287) | 2.76850203 |
| 68 | Constricted visual fields (HP:0001133) | 2.72494991 |
| 69 | Complement deficiency (HP:0004431) | 2.71707686 |
| 70 | Choroideremia (HP:0001139) | 2.68815524 |
| 71 | Gingival bleeding (HP:0000225) | 2.66860126 |
| 72 | Epistaxis (HP:0000421) | 2.66751163 |
| 73 | Gastrointestinal infarctions (HP:0005244) | 2.66727277 |
| 74 | Vasculitis (HP:0002633) | 2.66218845 |
| 75 | Gingivitis (HP:0000230) | 2.65454446 |
| 76 | Gait imbalance (HP:0002141) | 2.64714071 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.62667440 |
| 78 | Optic nerve hypoplasia (HP:0000609) | 2.61775531 |
| 79 | Recurrent viral infections (HP:0004429) | 2.60788032 |
| 80 | Keratoconjunctivitis sicca (HP:0001097) | 2.60377480 |
| 81 | Congenital primary aphakia (HP:0007707) | 2.58267393 |
| 82 | Autoimmune thrombocytopenia (HP:0001973) | 2.57348110 |
| 83 | Petechiae (HP:0000967) | 2.54395059 |
| 84 | Posterior subcapsular cataract (HP:0007787) | 2.53696749 |
| 85 | Nephrogenic diabetes insipidus (HP:0009806) | 2.53135931 |
| 86 | Medial flaring of the eyebrow (HP:0010747) | 2.52178466 |
| 87 | Myocardial infarction (HP:0001658) | 2.51753328 |
| 88 | Pulmonary infiltrates (HP:0002113) | 2.49122647 |
| 89 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.48465483 |
| 90 | Colitis (HP:0002583) | 2.48166737 |
| 91 | Hemoptysis (HP:0002105) | 2.47380073 |
| 92 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.46956992 |
| 93 | Abnormality of the septum pellucidum (HP:0007375) | 2.46170741 |
| 94 | Pustule (HP:0200039) | 2.44867081 |
| 95 | Episodic fever (HP:0001954) | 2.42576235 |
| 96 | Hepatosplenomegaly (HP:0001433) | 2.41125536 |
| 97 | Joint hemorrhage (HP:0005261) | 2.40472789 |
| 98 | Increased IgE level (HP:0003212) | 2.39699787 |
| 99 | Thrombocytosis (HP:0001894) | 2.38889125 |
| 100 | Abnormality of complement system (HP:0005339) | 2.37623012 |
| 101 | Keratoconjunctivitis (HP:0001096) | 2.36898322 |
| 102 | Abnormality of the lumbar spine (HP:0100712) | 2.34524222 |
| 103 | Encephalitis (HP:0002383) | 2.33007717 |
| 104 | Absence seizures (HP:0002121) | 2.31891578 |
| 105 | Spontaneous hematomas (HP:0007420) | 2.29567185 |
| 106 | Arterial thrombosis (HP:0004420) | 2.28881588 |
| 107 | Abnormality of iron homeostasis (HP:0011031) | 2.28752776 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.28489589 |
| 109 | True hermaphroditism (HP:0010459) | 2.25258259 |
| 110 | Urticaria (HP:0001025) | 2.24799366 |
| 111 | Thoracic kyphosis (HP:0002942) | 2.23988904 |
| 112 | Pulmonary embolism (HP:0002204) | 2.23375918 |
| 113 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 2.23187220 |
| 114 | Inflammation of the large intestine (HP:0002037) | 2.21968195 |
| 115 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 2.20845922 |
| 116 | Gastrointestinal inflammation (HP:0004386) | 2.19829290 |
| 117 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18524971 |
| 118 | Polyneuropathy (HP:0001271) | 2.16433192 |
| 119 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14393057 |
| 120 | Progressive cerebellar ataxia (HP:0002073) | 2.13774461 |
| 121 | Cholecystitis (HP:0001082) | 2.13201817 |
| 122 | Abnormal gallbladder physiology (HP:0012438) | 2.13201817 |
| 123 | Cellulitis (HP:0100658) | 2.11533711 |
| 124 | Spondylolisthesis (HP:0003302) | 2.10609336 |
| 125 | Progressive visual loss (HP:0000529) | 2.10336118 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 2.10102719 |
| 127 | Neuronal loss in central nervous system (HP:0002529) | 2.07811816 |
| 128 | Vitreoretinal degeneration (HP:0000655) | 2.05071246 |
| 129 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.03301530 |
| 130 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.02596457 |
| 131 | Poor coordination (HP:0002370) | 2.02056468 |
| 132 | Metaphyseal irregularity (HP:0003025) | 2.00795911 |
| 133 | Thrombophlebitis (HP:0004418) | 2.00290713 |
| 134 | Gangrene (HP:0100758) | 2.00076242 |
| 135 | Pancreatic fibrosis (HP:0100732) | 2.00035984 |
| 136 | Congenital stationary night blindness (HP:0007642) | 15.3258293 |
| 137 | Astigmatism (HP:0000483) | 1.99313722 |
| 138 | Growth hormone deficiency (HP:0000824) | 1.98819922 |
| 139 | Neurofibrillary tangles (HP:0002185) | 1.96208250 |
| 140 | Dialeptic seizures (HP:0011146) | 1.95104907 |
| 141 | Severe Myopia (HP:0011003) | 1.95095829 |
| 142 | Personality changes (HP:0000751) | 1.95026887 |
| 143 | Chest pain (HP:0100749) | 1.94463341 |
| 144 | Hemiparesis (HP:0001269) | 1.91211451 |
| 145 | Glomerulopathy (HP:0100820) | 1.90784295 |
| 146 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88869670 |
| 147 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.86325349 |
| 148 | Abnormality of the pleura (HP:0002103) | 1.85456295 |
| 149 | Vaginal atresia (HP:0000148) | 1.85341104 |
| 150 | Xanthomatosis (HP:0000991) | 1.84448906 |
| 151 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.83566609 |
| 152 | Abnormal pupillary function (HP:0007686) | 1.83305550 |
| 153 | Axonal loss (HP:0003447) | 1.82757155 |
| 154 | Genital tract atresia (HP:0001827) | 1.82475806 |
| 155 | Progressive neurologic deterioration (HP:0002344) | 1.82359116 |
| 156 | Leukocytosis (HP:0001974) | 1.81486224 |
| 157 | Chorioretinal coloboma (HP:0000567) | 1.81367186 |
| 158 | Granulocytopenia (HP:0001913) | 1.81119416 |
| 159 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.80606686 |
| 160 | Subcapsular cataract (HP:0000523) | 1.80269918 |
| 161 | T lymphocytopenia (HP:0005403) | 1.79266860 |
| 162 | Abnormality of the thoracic spine (HP:0100711) | 1.78991696 |
| 163 | Optic disc pallor (HP:0000543) | 1.76036132 |
| 164 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.74349408 |
| 165 | Abnormality of abdominal situs (HP:0011620) | 1.74141851 |
| 166 | Abdominal situs inversus (HP:0003363) | 1.74141851 |
| 167 | Generalized hypopigmentation (HP:0007513) | 1.73403262 |
| 168 | Prolonged QT interval (HP:0001657) | 1.72430482 |
| 169 | Abnormality of dental color (HP:0011073) | 1.70500913 |
| 170 | Pancreatic cysts (HP:0001737) | 1.66407227 |
| 171 | Wide nasal bridge (HP:0000431) | 1.56762935 |
| 172 | Dysdiadochokinesis (HP:0002075) | 1.55246144 |
| 173 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.52927469 |
| 174 | Abnormality of the sella turcica (HP:0002679) | 1.52298669 |
| 175 | Mutism (HP:0002300) | 1.49197156 |
| 176 | Focal motor seizures (HP:0011153) | 1.46756081 |
| 177 | Visual hallucinations (HP:0002367) | 1.44029177 |
| 178 | Abnormality of midbrain morphology (HP:0002418) | 1.42558960 |
| 179 | Molar tooth sign on MRI (HP:0002419) | 1.42558960 |
| 180 | Cystic liver disease (HP:0006706) | 1.37865736 |
| 181 | Neoplasm of the heart (HP:0100544) | 1.35677701 |
| 182 | EEG with generalized epileptiform discharges (HP:0011198) | 1.35182245 |
| 183 | Genetic anticipation (HP:0003743) | 1.33674159 |
| 184 | Partial agenesis of the corpus callosum (HP:0001338) | 1.32197658 |
| 185 | Epileptiform EEG discharges (HP:0011182) | 1.30482404 |
| 186 | Nephronophthisis (HP:0000090) | 1.29829623 |
| 187 | Optic atrophy (HP:0000648) | 1.26483874 |
| 188 | Generalized tonic-clonic seizures (HP:0002069) | 1.24882650 |
| 189 | Widely spaced teeth (HP:0000687) | 1.23140625 |
| 190 | Atrial fibrillation (HP:0005110) | 1.22862009 |
| 191 | Abnormality of the renal medulla (HP:0100957) | 1.21552039 |
| 192 | Decreased testicular size (HP:0008734) | 1.21516728 |
| 193 | Left ventricular hypertrophy (HP:0001712) | 1.21513619 |
| 194 | Increased cerebral lipofuscin (HP:0011813) | 1.19072358 |
| 195 | Abnormality of the parathyroid morphology (HP:0011766) | 1.17979261 |
| 196 | Primary adrenal insufficiency (HP:0008207) | 1.17133850 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.49244377 |
| 2 | RIPK4 | 4.01046441 |
| 3 | PRPF4B | 3.47248333 |
| 4 | GRK1 | 3.38499873 |
| 5 | BLK | 3.02915525 |
| 6 | INSRR | 2.90824667 |
| 7 | IRAK3 | 2.80843592 |
| 8 | MAP2K3 | 2.78193497 |
| 9 | PAK6 | 2.75813514 |
| 10 | EPHA3 | 2.67342437 |
| 11 | MAP4K1 | 2.65584919 |
| 12 | TAOK2 | 2.62223524 |
| 13 | MAP3K14 | 2.58831210 |
| 14 | TYK2 | 2.58785736 |
| 15 | ERN1 | 2.52179280 |
| 16 | NEK1 | 2.50050811 |
| 17 | STK38 | 2.28862676 |
| 18 | SIK3 | 2.26836081 |
| 19 | DYRK1A | 2.22850820 |
| 20 | STK38L | 2.18429363 |
| 21 | ZAP70 | 2.09864543 |
| 22 | TBK1 | 2.08874480 |
| 23 | CDK3 | 2.08099000 |
| 24 | MARK1 | 2.07922687 |
| 25 | CSK | 2.00289964 |
| 26 | CSF1R | 2.00115532 |
| 27 | PINK1 | 1.92640422 |
| 28 | TGFBR2 | 1.91686973 |
| 29 | IRAK4 | 1.91118657 |
| 30 | KIT | 1.90622165 |
| 31 | NME2 | 1.90284922 |
| 32 | CDK8 | 1.86276359 |
| 33 | PHKG1 | 1.86036175 |
| 34 | PHKG2 | 1.86036175 |
| 35 | TNIK | 1.85759132 |
| 36 | FGR | 1.84913136 |
| 37 | SIK2 | 1.83861268 |
| 38 | SYK | 1.73162850 |
| 39 | MATK | 1.63167093 |
| 40 | MAP3K3 | 1.61498880 |
| 41 | TNK2 | 1.58259751 |
| 42 | MAP3K11 | 1.57075926 |
| 43 | BTK | 1.48796230 |
| 44 | RIPK1 | 1.47626346 |
| 45 | TRIB3 | 1.43452368 |
| 46 | MAP3K13 | 1.43280761 |
| 47 | FES | 1.43051285 |
| 48 | IKBKB | 1.40855852 |
| 49 | GRK6 | 1.38430729 |
| 50 | LYN | 1.38020681 |
| 51 | PKN1 | 1.34505873 |
| 52 | GRK7 | 1.33350825 |
| 53 | IKBKE | 1.32292536 |
| 54 | SGK494 | 1.32060714 |
| 55 | SGK223 | 1.32060714 |
| 56 | CLK1 | 1.31925970 |
| 57 | DDR2 | 1.30860020 |
| 58 | CAMK1D | 1.30362861 |
| 59 | SIK1 | 1.29864597 |
| 60 | CASK | 1.27003008 |
| 61 | BRD4 | 1.26066411 |
| 62 | HCK | 1.25057819 |
| 63 | MAP3K7 | 1.24480659 |
| 64 | JAK3 | 1.24299677 |
| 65 | CDK6 | 1.23751384 |
| 66 | IRAK2 | 1.23330355 |
| 67 | NME1 | 1.21671705 |
| 68 | ICK | 1.20946025 |
| 69 | TESK2 | 1.20609741 |
| 70 | CAMK2D | 1.19573160 |
| 71 | MAP3K4 | 1.19036686 |
| 72 | TAOK1 | 1.17543843 |
| 73 | PRKAA1 | 1.08734263 |
| 74 | PDPK1 | 1.08661637 |
| 75 | MAP2K7 | 1.08215386 |
| 76 | CAMK1G | 1.07318988 |
| 77 | LCK | 1.06357520 |
| 78 | MINK1 | 1.06224636 |
| 79 | JAK1 | 1.06206624 |
| 80 | CAMK1 | 1.04396541 |
| 81 | FGFR4 | 1.04079689 |
| 82 | MAP3K1 | 1.03102313 |
| 83 | PDK1 | 1.02716459 |
| 84 | FGFR3 | 1.01560769 |
| 85 | MARK2 | 0.97283138 |
| 86 | WNK1 | 0.95892215 |
| 87 | PRKD2 | 0.94071263 |
| 88 | ITK | 0.94003793 |
| 89 | JAK2 | 0.91347744 |
| 90 | TEC | 0.89806996 |
| 91 | BMPR2 | 0.89449490 |
| 92 | MOS | 0.89378089 |
| 93 | TXK | 0.88701695 |
| 94 | AKT3 | 0.88208853 |
| 95 | CDK4 | 0.83452692 |
| 96 | SGK2 | 0.79100739 |
| 97 | PRKG1 | 0.76000423 |
| 98 | EPHA4 | 0.75626252 |
| 99 | TAOK3 | 0.74535863 |
| 100 | MAPK10 | 0.74519580 |
| 101 | FER | 0.73913101 |
| 102 | MAPK13 | 0.73273717 |
| 103 | RPS6KA5 | 0.72061103 |
| 104 | PRKCE | 0.71307545 |
| 105 | CAMKK2 | 0.71010285 |
| 106 | MAP2K6 | 0.70440472 |
| 107 | DYRK1B | 0.67461888 |
| 108 | PRKAA2 | 0.66805400 |
| 109 | TYRO3 | 0.66556278 |
| 110 | MAPK11 | 0.65859079 |
| 111 | CDK9 | 0.62945531 |
| 112 | EEF2K | 0.62071845 |
| 113 | MAPK7 | 0.62020437 |
| 114 | NEK6 | 0.61833291 |
| 115 | MAP3K5 | 0.61799046 |
| 116 | RPS6KC1 | 0.61673489 |
| 117 | RPS6KL1 | 0.61673489 |
| 118 | ERBB3 | 0.61140713 |
| 119 | CAMK4 | 0.60942899 |
| 120 | MAP3K6 | 0.60466530 |
| 121 | ZAK | 0.60429241 |
| 122 | MARK3 | 0.60226988 |
| 123 | STK10 | 0.59986917 |
| 124 | FLT3 | 0.59497313 |
| 125 | PKN2 | 0.59105316 |
| 126 | CAMK2A | 0.58091187 |
| 127 | ADRBK2 | 0.57197164 |
| 128 | CDK14 | 0.56530472 |
| 129 | PRKCA | 0.56296216 |
| 130 | GSK3B | 0.56077812 |
| 131 | CDK5 | 0.55842284 |
| 132 | SGK1 | 0.55392393 |
| 133 | YES1 | 0.54318958 |
| 134 | ERBB2 | 0.54148763 |
| 135 | CDK12 | 0.53312044 |
| 136 | IRAK1 | 0.53275468 |
| 137 | PIK3CG | 0.52225825 |
| 138 | BMPR1B | 0.51206248 |
| 139 | KSR2 | 0.50441022 |
| 140 | CSNK1D | 0.50109588 |
| 141 | PRKCB | 0.49215443 |
| 142 | PRKCG | 0.49096262 |
| 143 | PRKACA | 0.49087889 |
| 144 | RPS6KA3 | 0.48799161 |
| 145 | RPS6KA6 | 0.48676621 |
| 146 | CHUK | 0.47353450 |
| 147 | PRKCZ | 0.47101740 |
| 148 | HIPK2 | 0.46950635 |
| 149 | NTRK3 | 0.46593553 |
| 150 | SGK3 | 0.46358109 |
| 151 | MAPK4 | 0.46112968 |
| 152 | MAPK14 | 0.45280108 |
| 153 | CDK15 | 0.44883615 |
| 154 | MAPK9 | 0.44588386 |
| 155 | CHEK2 | 0.43193374 |
| 156 | ABL2 | 0.42796855 |
| 157 | CDC42BPA | 0.41902907 |
| 158 | CDK18 | 0.41773839 |
| 159 | PAK3 | 0.41412320 |
| 160 | PIM1 | 0.40821859 |
| 161 | NEK9 | 0.40638596 |
| 162 | SMG1 | 0.40001553 |
| 163 | FYN | 0.38693624 |
| 164 | ROCK2 | 0.38447649 |
| 165 | CDK11A | 0.38149923 |
| 166 | PRKCQ | 0.37198427 |
| 167 | MAPKAPK2 | 0.37150597 |
| 168 | PLK3 | 0.36723810 |
| 169 | RET | 0.36174441 |
| 170 | PIM2 | 0.35939911 |
| 171 | MAPK8 | 0.35564825 |
| 172 | MAPK12 | 0.34443589 |
| 173 | AKT2 | 0.33933800 |
| 174 | NTRK2 | 0.33838844 |
| 175 | MAPK3 | 0.29301736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 7.92631532 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 4.72726399 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 4.35120205 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.64350639 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.53132497 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.32055508 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 3.24501060 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.09039784 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.88859669 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.81894415 |
| 11 | Circadian rhythm_Homo sapiens_hsa04710 | 2.64116249 |
| 12 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.30237045 |
| 13 | Circadian entrainment_Homo sapiens_hsa04713 | 2.28073443 |
| 14 | Allograft rejection_Homo sapiens_hsa05330 | 2.24412163 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.23667838 |
| 16 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.18960055 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 2.18618594 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12408062 |
| 19 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.11231341 |
| 20 | Asthma_Homo sapiens_hsa05310 | 2.09413616 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 2.09009916 |
| 22 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.99385656 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.93418631 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88265710 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.87916139 |
| 26 | Pertussis_Homo sapiens_hsa05133 | 1.85228578 |
| 27 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.83825315 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.74784415 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.72078656 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.69870272 |
| 31 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.68702424 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.67504646 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.65940652 |
| 34 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.65550478 |
| 35 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64305062 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63955389 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.60015173 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.58752658 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57770191 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.54930410 |
| 41 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54186010 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.52565050 |
| 43 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.52063387 |
| 44 | Influenza A_Homo sapiens_hsa05164 | 1.51280777 |
| 45 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50497352 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49128394 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.48040308 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.44955549 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44842367 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.43306056 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39037521 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38450575 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36334030 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.29699198 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 1.25815142 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23007043 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.21359289 |
| 58 | Measles_Homo sapiens_hsa05162 | 1.20737032 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.19971113 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 1.18844726 |
| 61 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.18825382 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.18812030 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 1.16951403 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.16811943 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11485137 |
| 66 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10907347 |
| 67 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.09410722 |
| 68 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.08728463 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.08224686 |
| 70 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.08002494 |
| 71 | Viral myocarditis_Homo sapiens_hsa05416 | 1.07486364 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.07014407 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01204453 |
| 74 | Hepatitis B_Homo sapiens_hsa05161 | 0.99840980 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97230391 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.97221511 |
| 77 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94730084 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.92325007 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.91693932 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91511718 |
| 81 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89771499 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.87554295 |
| 83 | Platelet activation_Homo sapiens_hsa04611 | 0.86814919 |
| 84 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.82970588 |
| 85 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82342774 |
| 86 | * Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81755598 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.80826622 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | 0.79855727 |
| 89 | Shigellosis_Homo sapiens_hsa05131 | 0.79352970 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.77203911 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.76750406 |
| 92 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75949213 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.75836130 |
| 94 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.75068559 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74840099 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.74643146 |
| 97 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73935247 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.72879812 |
| 99 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.71602234 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.70490846 |
| 101 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.70191478 |
| 102 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69836246 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.69666787 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.69276752 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66913670 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.66639402 |
| 107 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66005779 |
| 108 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.63563207 |
| 109 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62022143 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61777533 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61108590 |
| 112 | Galactose metabolism_Homo sapiens_hsa00052 | 0.60831876 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60780106 |
| 114 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60639447 |
| 115 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58546527 |
| 116 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.57984335 |
| 117 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55941274 |
| 118 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55623696 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.54412632 |
| 120 | Insulin resistance_Homo sapiens_hsa04931 | 0.54364562 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.53466523 |
| 122 | Axon guidance_Homo sapiens_hsa04360 | 0.53173231 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51036431 |
| 124 | Long-term depression_Homo sapiens_hsa04730 | 0.50678283 |
| 125 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48253949 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47063563 |
| 127 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47019974 |
| 128 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46922890 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.46805466 |
| 130 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45675760 |
| 131 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44005852 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.43232634 |
| 133 | Retinol metabolism_Homo sapiens_hsa00830 | 0.42207346 |
| 134 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40611581 |
| 135 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.40318321 |
| 136 | Alcoholism_Homo sapiens_hsa05034 | 0.39977422 |
| 137 | Purine metabolism_Homo sapiens_hsa00230 | 0.38093819 |
| 138 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.37748299 |
| 139 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37302990 |
| 140 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36796865 |
| 141 | Cocaine addiction_Homo sapiens_hsa05030 | 0.36009379 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33403002 |
| 143 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33249420 |
| 144 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32858206 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32647247 |
| 146 | Lysine degradation_Homo sapiens_hsa00310 | 0.32139312 |
| 147 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31575298 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31002580 |
| 149 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.30871103 |
| 150 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29679577 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.28932958 |
| 152 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28449937 |
| 153 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27989706 |
| 154 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26408727 |
| 155 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.25308035 |
| 156 | Melanoma_Homo sapiens_hsa05218 | 0.24839299 |
| 157 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24817956 |
| 158 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23636523 |
| 159 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.23485725 |
| 160 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22807117 |
| 161 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.21100815 |
| 162 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20227941 |
| 163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20021040 |
| 164 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.19783217 |
| 165 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.19141854 |
| 166 | Lysosome_Homo sapiens_hsa04142 | 0.17386359 |
| 167 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.17353041 |
| 168 | Colorectal cancer_Homo sapiens_hsa05210 | 0.16489812 |
| 169 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.15497097 |
| 170 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.13657659 |
| 171 | Bile secretion_Homo sapiens_hsa04976 | 0.12964459 |
| 172 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.12922124 |
| 173 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.12413285 |
| 174 | Endocytosis_Homo sapiens_hsa04144 | 0.11378320 |
| 175 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10025973 |

